Literature DB >> 17705011

Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.

Seiji Kurata1, Masatoshi Ishibashi, Yuji Hiromatsu, Hayato Kaida, Ikuyo Miyake, Masafumi Uchida, Naofumi Hayabuchi.   

Abstract

OBJECTIVE: To investigate and evaluate the prevalence of incidental thyroid diffuse and diffuse-plus-focal fluorine-18 fluorodeoxyglucose (FDG) uptake in healthy subjects who underwent cancer screening on positron emission tomography (PET) scan, and also to evaluate the prevalence of thyroid cancer and Hashimoto's thyroiditis.
METHODS: We carried out a retrospective review of 1626 subjects who underwent PET scanning at our institution. Diffuse uptake was defined as FDG uptake in the whole thyroid gland, whereas diffuse-plus-focal uptake was defined as a thyroid lesion with both diffuse uptake and focal FDG uptake. The maximum standardized uptake value of the thyroid lesions was recorded and reviewed. In each selected subject with positive thyroid FDG uptake, serum thyroid-stimulating hormone, thyroid hormone, and thyroid antibodies were measured. Fine needle aspiration cytology was performed on patients with a definite nodule using ultrasonography.
RESULTS: Twenty-nine subjects (1.78%) were identified as having either diffuse FDG uptake (n = 25, 1.53%) or diffuse-plus-focal FDG uptake (n = 4, 0.24%). All subjects with diffuse FDG uptake were diagnosed as having Hashimoto's thyroiditis. In 1 of the 25 subjects with diffuse FDG uptake and two of the four with diffuse-plus-focal FDG uptake, histopathologic diagnosis showed papillary thyroid carcinoma associated with Hashimoto's thyroiditis. However, PET scan did not detect papillary carcinoma associated with Hashimoto's thyroiditis in one of the three subjects.
CONCLUSIONS: Our results suggest that although diffuse FDG uptake usually indicates Hashimoto's thyroiditis, the risk of thyroid cancer must be recognized in both diffuse FDG uptake and diffuse-plus-focal FDG uptake on PET scan.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705011     DOI: 10.1007/s12149-007-0030-2

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  18 in total

1.  Clinical Significance of Diffuse (18)F-FDG Uptake in Residual Thyroid Gland after Unilateral Thyroid Lobectomy.

Authors:  Hee-Sung Song; Su Jin Lee; Seok-Ho Yoon; Jandee Lee; Euy-Young Soh; Young-Sil An; Joon-Kee Yoon
Journal:  Nucl Med Mol Imaging       Date:  2011-07-26

2.  The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.

Authors:  Sinae Lee; Taegyu Park; Soyeon Park; Kisoo Pahk; Seunghong Rhee; Jaehyuk Cho; Eugene Jeong; Sungeun Kim; Jae Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2013-12-06

3.  Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact.

Authors:  Sharouz Bonabi; Felix Schmidt; Martina A Broglie; Sarah R Haile; Sandro J Stoeckli
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12       Impact factor: 2.503

Review 4.  Clinical significance of patterns of increased [18F]-FDG uptake in the thyroid gland: a pictorial review.

Authors:  Fumihiro Tsubaki; Seiji Kurata; Junichi Tani; Akiko Sumi; Kiminori Fujimoto; Toshi Abe
Journal:  Jpn J Radiol       Date:  2017-12-27       Impact factor: 2.374

5.  Unfolding the role of PET FDG scan in the management of thyroid incidentaloma in cancer patients.

Authors:  Haim Gavriel; Adrian Tang; Ephraim Eviatar; Sor Way Chan
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-06       Impact factor: 2.503

Review 6.  The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.

Authors:  Brian Hung-Hin Lang; Tsz Ting Law
Journal:  Oncologist       Date:  2011-03-04

7.  Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism.

Authors:  Ivey N Rothman; Laura Middleton; Brendan C Stack; Twyla Bartel; Ann T Riggs; Donald L Bodenner
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-16       Impact factor: 2.503

8.  Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.

Authors:  A Reum Chun; Hye Min Jo; Seoung Ho Lee; Hong Woo Chun; Jung Mi Park; Kyu Jin Kim; Chan Hee Jung; Ji Oh Mok; Sung Koo Kang; Chul Hee Kim; Bo Yeon Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2014-07-18

9.  Diffuse thyroid uptake incidentally found on 18F-fluorodeoxyglucose positron emission tomography in subjects without cancer history.

Authors:  Ji Young Lee; Joon Young Choi; Yoon-Ho Choi; Seung Hyup Hyun; Seung Hwan Moon; Su Jin Jang; Yearn Seong Choe; Kyung-Han Lee; Byung-Tae Kim
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

10.  Risk of malignancy in focal thyroid lesions identified by (18)F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography: evidence from a large series of studies.

Authors:  Ning Qu; Ling Zhang; Zhong-wu Lu; Wen-jun Wei; Yan Zhang; Qing-hai Ji
Journal:  Tumour Biol       Date:  2014-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.